Somatostatin Receptors in Thyroid Tumors
Author Information
Author(s): Tisell L E, Ahlman H, Wängberg B, Kölby L, Fjälling M, Forssell-Aronsson E, Mölne J, Nilsson O
Primary Institution: Sahlgrenska University Hospital, Göteborg, Sweden
Hypothesis
The study investigates the expression of somatostatin receptors in Hürthle cell neoplasia of the thyroid.
Conclusion
Octreotide scintigraphy can effectively localize Hürthle cell tumors and visualize metastases in certain cases.
Supporting Evidence
- Octreotide scintigraphy localized the primary Hürthle cell tumor in eight patients.
- Two patients with Hürthle cell carcinoma had their metastases visualized by octreotide scintigraphy.
- Higher expression of somatostatin receptors was observed in tumor lesions compared to normal thyroid tissue.
Takeaway
Doctors used a special scan to find tumors in patients' thyroids, and it worked well for most of them.
Methodology
Ten patients with Hürthle cell lesions underwent octreotide scintigraphy to assess somatostatin receptor expression.
Limitations
The study had a small sample size and potential misinterpretations due to high uptake in goiter tissue.
Participant Demographics
Patients with Hürthle cell lesions of the thyroid.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website